Beyond Pain Scores: Can Palm Tocotrienols Modify Diabetic Peripheral Neuropathy? Reconciling Nerve-Conduction Gains With Inconsistent Symptom Relief
DOI:
https://doi.org/10.59890/ijnhs.v4i4.11Keywords:
Diabetic Peripheral Neuropathy, Tocotrienols, Palm Vitamin E, Nerve Conduction Velocity, Nerve Growth Factor, Neuropathic Pain, Oxidative Stress, Small-Fiber Neuropathy, Neuroregeneration; Disease ModificationAbstract
Diabetic peripheral neuropathy (DPN) is a prevalent and disabling complication of diabetes characterized by sensory loss, neuropathic pain, impaired balance, foot ulceration risk, and progressive deterioration of peripheral nerve function. Its pathogenesis extends beyond hyperglycemia and involves oxidative stress, mitochondrial dysfunction, advanced glycation, neuroinflammation, microvascular impairment, disrupted neurotrophic signaling, Schwann-cell dysfunction, and progressive axonal degeneration. Because currently available pharmacological therapies predominantly target neuropathic pain rather than the underlying neural injury, interest has grown in compounds capable of modifying several pathogenic pathways simultaneously. Palm-derived tocotrienols are of particular interest because clinical studies have demonstrated measurable improvements in selected sensory and motor nerve-conduction parameters and increases in circulating nerve growth factor. However, electrophysiological improvement has not consistently translated into comparable symptomatic relief, while some gains diminish following treatment withdrawal. This critical qualitative review synthesizes peer-reviewed evidence published from January 2020 through December 2024 to explain this apparent discordance. The review argues that nerve-conduction velocity, small-fiber integrity, neuropathic pain, and functional recovery represent overlapping but non-equivalent domains of DPN. Current evidence supports biological and electrophysiological activity of tocotrienol-rich vitamin E but remains insufficient to demonstrate durable structural neuroregeneration or definitive disease modification. Future trials should prioritize early-stage DPN, patient stratification, pharmacokinetic characterization, multidomain neurological endpoints, and post-treatment follow-up
References
Alam, U., Sloan, G. and Tesfaye, S. (2020) ‘Treating pain in diabetic neuropathy: Current and developmental drugs’, Drugs, 80, pp. 363–384. Available at: https://doi.org/10.1007/s40265-020-01259-2.
Aso, Y. (2022) ‘Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches’, Journal of Diabetes Investigation, 13(3), pp. 432–434. Available at: https://doi.org/10.1111/jdi.13711.
Atmaca, A. et al. (2024) ‘Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: A multidisciplinary approach’, Frontiers in Endocrinology, 15, 1380929. Available at: https://doi.org/10.3389/fendo.2024.1380929.
Basem, J., Bah, F. and Mehta, N. (2023) ‘A brief review on the novel therapies for painful diabetic neuropathy’, Current Pain and Headache Reports, 27, pp. 299–305. Available at: https://doi.org/10.1007/s11916-023-01126-1.
Calcutt, N.A. (2020) ‘Diabetic neuropathy and neuropathic pain: A (con)fusion of pathogenic mechanisms?’, Pain, 161(Suppl. 1), pp. S65–S86. Available at: https://doi.org/10.1097/j.pain.0000000000001922.
Dhage, S. et al. (2021) ‘Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy’, Scientific Reports, 11, 1859. Available at: https://doi.org/10.1038/s41598-021-81302-8.
Dillon, B.R., Ang, L. and Pop-Busui, R. (2024) ‘Spectrum of diabetic neuropathy: New insights in diagnosis and treatment’, Annual Review of Medicine, 75, pp. 293–306. Available at: https://doi.org/10.1146/annurev-med-043021-033114.
Fairus, S., Cheng, H.M. and Sundram, K. (2020) ‘Antioxidant status following postprandial challenge of two different doses of tocopherols and tocotrienols’, Journal of Integrative Medicine, 18(1), pp. 68–79. Available at: https://doi.org/10.1016/j.joim.2019.11.005.
Gad, H., Petropoulos, I.N., Khan, A., Ponirakis, G., MacDonald, R., Alam, U. and Malik, R.A. (2022) ‘Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: A systematic review and meta-analysis’, Journal of Diabetes Investigation, 13(1), pp. 134–147. Available at: https://doi.org/10.1111/jdi.13643.
Ismail, M. et al. (2020) ‘Safety and neuroprotective efficacy of palm oil and tocotrienol-rich fraction from palm oil: A systematic review’, Nutrients, 12(2), 521. Available at: https://doi.org/10.3390/nu12020521.
James, C.F. et al. (2022) ‘Pharmacotherapy of painful diabetic neuropathy: A clinical update’, Şişli Etfal Hastanesi Tıp Bülteni, 56(1), pp. 1–20. Available at: https://doi.org/10.14744/SEMB.2021.54670.
Kobayashi, M. and Zochodne, D.W. (2020) ‘Diabetic polyneuropathy: Bridging the translational gap’, Journal of the Peripheral Nervous System, 25, pp. 66–75. Available at: https://doi.org/10.1111/jns.12392.
Lian, Y. et al. (2021) ‘Different drugs for the treatment of painful diabetic peripheral neuropathy: A meta-analysis’, Frontiers in Neurology, 12, 682244. Available at: https://doi.org/10.3389/fneur.2021.682244.
Malik, R.A. (2020) ‘Diabetic neuropathy: A focus on small fibres’, Diabetes/Metabolism Research and Reviews, 36(S1), e3255. Available at: https://doi.org/10.1002/dmrr.3255.
Mallick-Searle, T. and Adler, J.A. (2024) ‘Update on treating painful diabetic peripheral neuropathy: A review of current US guidelines with a focus on the most recently approved management options’, Journal of Pain Research, 17. Available at: https://doi.org/10.2147/JPR.S442595.
Naruse, K. (2024) ‘Advances in diagnostic methods for early-stage diabetic polyneuropathy’, Journal of Diabetes Investigation, 15(7), pp. 820–822. Available at: https://doi.org/10.1111/jdi.14201.
Nasr-Eldin, M. et al. (2024) ‘Evaluation of serum neurofilament light chain and nerve ultrasound in diabetic neuropathy’, Journal of Ultrasound in Medicine, 43, pp. 683–696. Available at: https://doi.org/10.1002/jum.16393.
Ng, Y.T., Phang, S.C.W., Tan, G.C.J., Ng, E.Y., Henien, N.P.B., Palanisamy, U.D.M., Ahmad, B. and Abdul Kadir, K. (2020) ‘The effects of tocotrienol-rich vitamin E (Tocovid) on diabetic neuropathy: A phase II randomized controlled trial’, Nutrients, 12(5), 1522. Available at: https://doi.org/10.3390/nu12051522.
Pang, L. et al. (2020) ‘Understanding diabetic neuropathy: Focus on oxidative stress’, Oxidative Medicine and Cellular Longevity, 2020, 9524635. Available at: https://doi.org/10.1155/2020/9524635.
Ratan, Y. et al. (2024) ‘Recent advances in biomolecular patho-mechanistic pathways behind the development and progression of diabetic neuropathy’, Biomedicines, 12(7), 1390. Available at: https://doi.org/10.3390/biomedicines12071390.
Sayed, D. et al. (2024) ‘A systematic guideline by the ASPN Workgroup on the evidence, education, and treatment algorithm for painful diabetic neuropathy: SWEET’, Journal of Pain Research, 17, pp. 1461–1501. Available at: https://doi.org/10.2147/JPR.S451006.
Sharif, M. et al. (2023) ‘Pharmacokinetics and bioavailability of tocotrienols in healthy human volunteers: A systematic review’, Journal of the Pakistan Medical Association, 73(3), pp. 603–610. Available at: https://doi.org/10.47391/JPMA.6008.
Twiddy, M. et al. (2021) ‘A consideration of the psychological aspects to managing patients with painful diabetic neuropathy: An insight into pain and quality of life’, Diabetes Therapy, 12, pp. 487–498. Available at: https://doi.org/10.1007/s13300-020-00983-y.
Vileikyte, L. (2023) ‘Quality of life of persons with painful diabetic neuropathy: How can we improve it?’, Diabetes Research and Clinical Practice, 206, 110756. Available at: https://doi.org/10.1016/j.diabres.2023.110756.
Yang, J. et al. (2021) ‘Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy’, Journal of Diabetes Investigation, 12(5), pp. 828–836. Available at: https://doi.org/10.1111/jdi.13394.
Ziegler, D. (2023) ‘Pathogenetic treatments for diabetic peripheral neuropathy’, Diabetes Research and Clinical Practice, 206(Suppl. 1), 110764. Available at: https://doi.org/10.1016/j.diabres.2023.110764.
Ziegler, D. et al. (2021) ‘Current concepts in the management of diabetic polyneuropathy’, Journal of Diabetes Investigation, 12(4), pp. 464–475. Available at: https://doi.org/10.1111/jdi.13401.
